- Home
- SRM vs CYCN Comparison
SRM vs CYCN Comparison
Compare SRM & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- CYCN
- Stock Information
- Founded
- SRM 1979
- CYCN 2018
- Country
- SRM United States
- CYCN United States
- Employees
- SRM N/A
- CYCN N/A
- Industry
- SRM
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- CYCN Health Care
- Exchange
- SRM Nasdaq
- CYCN Nasdaq
- Market Cap
- SRM 9.0M
- CYCN 8.4M
- IPO Year
- SRM 2023
- CYCN N/A
- Fundamental
- Price
- SRM $0.79
- CYCN $2.82
- Analyst Decision
- SRM
- CYCN
- Analyst Count
- SRM 0
- CYCN 0
- Target Price
- SRM N/A
- CYCN N/A
- AVG Volume (30 Days)
- SRM 17.4M
- CYCN 5.8M
- Earning Date
- SRM 03-31-2025
- CYCN 03-04-2025
- Dividend Yield
- SRM N/A
- CYCN N/A
- EPS Growth
- SRM N/A
- CYCN N/A
- EPS
- SRM N/A
- CYCN N/A
- Revenue
- SRM $4,594,304.00
- CYCN $194,000.00
- Revenue This Year
- SRM N/A
- CYCN N/A
- Revenue Next Year
- SRM N/A
- CYCN N/A
- P/E Ratio
- SRM N/A
- CYCN N/A
- Revenue Growth
- SRM N/A
- CYCN N/A
- 52 Week Low
- SRM $0.30
- CYCN $1.27
- 52 Week High
- SRM $1.85
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- SRM 66.62
- CYCN 43.92
- Support Level
- SRM $0.30
- CYCN $2.89
- Resistance Level
- SRM $0.93
- CYCN $4.80
- Average True Range (ATR)
- SRM 0.08
- CYCN 0.66
- MACD
- SRM 0.07
- CYCN -0.13
- Stochastic Oscillator
- SRM 62.33
- CYCN 6.03
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.